Cargando…

Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica

Calculation of the maximum recommended dose of local anesthetic minimizes the risk of Local Anesthetic Systemic Toxicity (LAST) when administrating multiple blocks for lower limb surgeries. Ropivacaine is the preferred local anesthetic as it is less lipophilic than bupivacaine and thus results in le...

Descripción completa

Detalles Bibliográficos
Autores principales: Aditya, Ashish, Amar, Paritosh, Chander, Anjuman, Goel, Nitika, Jain, Kajal, Samra, Tanvir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265418/
https://www.ncbi.nlm.nih.gov/pubmed/34100399
http://dx.doi.org/10.4103/ijp.IJP_521_20
_version_ 1783719760716890112
author Aditya, Ashish
Amar, Paritosh
Chander, Anjuman
Goel, Nitika
Jain, Kajal
Samra, Tanvir
author_facet Aditya, Ashish
Amar, Paritosh
Chander, Anjuman
Goel, Nitika
Jain, Kajal
Samra, Tanvir
author_sort Aditya, Ashish
collection PubMed
description Calculation of the maximum recommended dose of local anesthetic minimizes the risk of Local Anesthetic Systemic Toxicity (LAST) when administrating multiple blocks for lower limb surgeries. Ropivacaine is the preferred local anesthetic as it is less lipophilic than bupivacaine and thus results in less central nervous system (CNS) and cardiovascular toxicity. The presence of developmental, congenital, and metabolic disorders mandates an extracautious approach in the administration of large volume of Local anaesthesia (LA) as the vascularity of the limb, levels of alpha-1-acid glycoprotein, and sensitivity of the sodium channels may be altered. This case report highlights successful resuscitation of a patient with Phacomatosis pigmentokeratotica after the development of CNS toxicity secondary to the administration of ropivacaine in ultrasound-guided combined lumbar plexus and sciatic nerve block. We identified some high risk patient profiles which should be vigilantly monitored to minimize the incidence of LAST.
format Online
Article
Text
id pubmed-8265418
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-82654182021-07-16 Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica Aditya, Ashish Amar, Paritosh Chander, Anjuman Goel, Nitika Jain, Kajal Samra, Tanvir Indian J Pharmacol Drug Watch Calculation of the maximum recommended dose of local anesthetic minimizes the risk of Local Anesthetic Systemic Toxicity (LAST) when administrating multiple blocks for lower limb surgeries. Ropivacaine is the preferred local anesthetic as it is less lipophilic than bupivacaine and thus results in less central nervous system (CNS) and cardiovascular toxicity. The presence of developmental, congenital, and metabolic disorders mandates an extracautious approach in the administration of large volume of Local anaesthesia (LA) as the vascularity of the limb, levels of alpha-1-acid glycoprotein, and sensitivity of the sodium channels may be altered. This case report highlights successful resuscitation of a patient with Phacomatosis pigmentokeratotica after the development of CNS toxicity secondary to the administration of ropivacaine in ultrasound-guided combined lumbar plexus and sciatic nerve block. We identified some high risk patient profiles which should be vigilantly monitored to minimize the incidence of LAST. Wolters Kluwer - Medknow 2021 2021-05-26 /pmc/articles/PMC8265418/ /pubmed/34100399 http://dx.doi.org/10.4103/ijp.IJP_521_20 Text en Copyright: © 2021 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Drug Watch
Aditya, Ashish
Amar, Paritosh
Chander, Anjuman
Goel, Nitika
Jain, Kajal
Samra, Tanvir
Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica
title Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica
title_full Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica
title_fullStr Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica
title_full_unstemmed Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica
title_short Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica
title_sort ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265418/
https://www.ncbi.nlm.nih.gov/pubmed/34100399
http://dx.doi.org/10.4103/ijp.IJP_521_20
work_keys_str_mv AT adityaashish ropivacaineinducedsystemictoxicityinapatientwithphacomatosispigmentokeratotica
AT amarparitosh ropivacaineinducedsystemictoxicityinapatientwithphacomatosispigmentokeratotica
AT chanderanjuman ropivacaineinducedsystemictoxicityinapatientwithphacomatosispigmentokeratotica
AT goelnitika ropivacaineinducedsystemictoxicityinapatientwithphacomatosispigmentokeratotica
AT jainkajal ropivacaineinducedsystemictoxicityinapatientwithphacomatosispigmentokeratotica
AT samratanvir ropivacaineinducedsystemictoxicityinapatientwithphacomatosispigmentokeratotica